医学
细胞因子释放综合征
嵌合抗原受体
多发性骨髓瘤
内科学
队列
细胞因子
抗原
肿瘤科
汽车T细胞治疗
T细胞
免疫系统
免疫学
作者
Sham Mailankody,Sean M. Devlin,Jonathan Landa,Karthik Nath,Claudia Diamonte,Elizabeth J. Carstens,Douglas Russo,Romany Auclair,Lisa Fitzgerald,Briana Cadzin,Xiuyan Wang,Devanjan Sikder,Brigitte Sénéchal,Vladimir P. Bermudez,Terence J. Purdon,Kinga Hosszu,Devin McAvoy,Tasmin Farzana,Elena Mead,Jessica Wilcox
标识
DOI:10.1056/nejmoa2209900
摘要
The results of this study of a GPRC5D-targeted CAR T-cell therapy (MCARH109) confirm that GPRC5D is an active immunotherapeutic target in multiple myeloma. (Funded by Juno Therapeutics/Bristol Myers Squibb; ClinicalTrials.gov number, NCT04555551.).
科研通智能强力驱动
Strongly Powered by AbleSci AI